Respiratory syncytial virus (RSV) is a common cause of seasonal respiratory viral infection
in patients who have undergone hematopoietic stem cell transplantation. RSV usually …

Though several antivirals have been developed and marketed to treat influenza virus
infections, the development of antiviral agents with clinical activity against other respiratory …

Umbilical cord blood (UCB) is increasingly used as an alternative source of hematopoietic
stem cells for transplantation for patients who lack a suitable sibling donor. Despite concerns …

Respiratory viruses (RVs) are known to be major causes of morbidity and mortality in
recipients of hematopoietic stem cell transplants (HSCTs), but prospective long-term studies …

Parainfluenza viral infections are increasingly recognized as common causes of morbidity
and mortality in cancer patients, particularly in hematopoietic cell transplant (HCT) recipients …

Reduced-intensity conditioned (RIC) hematopoietic stem cell transplantation (HSCT) has
improved the accessibility of transplantation in patients previously ineligible. We report the …

Respiratory virus infections in hematopoietic cell transplant (HCT) recipients are a major
cause of morbidity and mortality. While respiratory syncytial virus (RSV), human …

We report results in 41 consecutive patients with chronic lymphocytic leukemia (CLL) who
underwent allogeneic hematopoietic cell transplantation (HCT) after fludarabine, melphalan …

Background We conducted a global comprehensive literature review of observational
studies reporting respiratory syncytial virus (RSV) incidence in adults and determined …

Respiratory viral infections (RVIs) are common causes of mild illness in immunocompetent
children and adults with rare occurrences of significant morbidity or mortality. Complications …